Project Details
Description
Efficacy and safety of SAR156597 in the treatment of Idiopathic pulmonary Fibrosis (IPF): A randomized, double-blind, placebo-controlled, 52-week dose-ranging study
| Status | Finished |
|---|---|
| Effective start/end date | 6/23/15 → 8/15/18 |
Funding
- SANOFI-AVENTIS US
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.